CLOV Stock Analysis: Buy, Sell, or Hold?
CLOV - Clover Health Investments, Corp
$3.89
0.05 (1.44%)
▲
5d:
-0.89%
30d:
+37.77%
90d:
+94.25%
WAIT
LOW Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Smart Money Distribution
None View Scanner →
Strength: 6.1/10
Get Alerted When CLOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CLOV shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CLOV shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CLOV is currently trading at $3.88, which is considered extended relative to its 30-day fair value range of $2.82 to $3.81. From a valuation perspective, the stock is trading at a premium (Forward PE: 38.3) compared to its historical average (33.2). At these levels, the market is pricing in 4.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CLOV is in a uptrend. Immediate support is located at $3.45, while resistance sits at $4.23.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $2.82. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLOV is in a uptrend. Immediate support is located at $3.45, while resistance sits at $4.23.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $2.82. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.82 -
$3.81
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
40.5%
Protect Your Profits
Holding CLOV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 26.5% above Wall St target ($2.82)
- NEUTRAL: Trading at premium valuation - market expects 4.9% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$2.82 -
$3.81
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.45
Resistance Level
$4.23
Current Trend
Uptrend
Technical data as of
Jun 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
38.30
Wall Street Target
$2.82
(-26.5%)
Revenue Growth (YoY)
62.0%
Profit Margin
-2.6%
Valuation Premium vs History
+4.9% premium
PE vs Historical
38.3 vs 33.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.9%
(market-implied from PE analysis)
1-Year Target
$4.02
(+5%)
2-Year Target
$4.21
(+10%)
3-Year Target
$4.42
(+15%)
3-Yr Target (if PE normalizes)
(PE: 38→33)
PE COMPRESSION
$3.83
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 38.3, Growth: 11.1%)
$5.25
(+37%)
Base:
(SPY PE: 21.9, Growth: 11.1%)
$3.01
(-22%)
Bear:
(PE: 18.6, Growth: 11.1%)
$2.55
(-33%)
Share & Embed Analysis
Last updated: June 08, 2026 11:42 AM ET
Data refreshes hourly during market hours. Next update: 12:42 PM
Data refreshes hourly during market hours. Next update: 12:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLOV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Brady Patrick Priest
SELL
175000 shares
2026-03-04
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$103 | 64 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$405 | 59 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 56 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$411 | 57 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$290 | 58 HOLD |
Advanced CLOV Option Strategies
Professional options setups generated by AI based on today's CLOV price and gamma walls.
